A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)

NCT05181241 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Dimolegin

Sponsor

PharmaDiall Ltd.